WHITEHAWK THERAPEUTICS, INC. Interest Income (Expense), Nonoperating, Net
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Interest Income (Expense), Nonoperating, Net of $2.67 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-11.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2021-08-11
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2021-06-30 was $2.67K, a 86.72% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2021-03-31 was $3.04K, a 97.39% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2020-12-31 was $2.35K, a 98.60% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for the quarter ending 2020-09-30 was $9.00K, a 96.24% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2020 was $147.85K, a 85.66% decline from fiscal 2019.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2019 was $1.03M, a 32.46% increase from fiscal 2018.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2018 was $778.22K.
- WHITEHAWK THERAPEUTICS, INC. interest income (expense), nonoperating, net for fiscal 2017 was -$105.78K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2021-06-30 | $2.67K 10-Q · filed 2021-08-11 | $5.71K 10-Q · filed 2021-08-11 | $8.06K derived: sum of 3 quarters · filed 2021-08-11 | $17.07K derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $3.04K 10-Q · filed 2021-05-17 | $5.39K derived: sum of 2 quarters · filed 2021-05-17 | $14.39K derived: sum of 3 quarters · filed 2021-05-17 | $34.51K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-12-31 | $2.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $11.36K derived: sum of 2 quarters · filed 2021-03-11 | $31.48K derived: sum of 3 quarters · filed 2021-08-11 | $147.85K 10-K · filed 2021-03-11 |
| 2020-09-30 | $9.00K 10-Q · filed 2020-11-10 | $29.12K derived: sum of 2 quarters · filed 2021-08-11 | $145.49K 10-Q · filed 2020-11-10 | $313.43K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | $20.12K 10-Q · filed 2021-08-11 | $136.49K 10-Q · filed 2021-08-11 | $304.42K derived: sum of 3 quarters · filed 2021-08-11 | $543.83K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $116.37K 10-Q · filed 2021-05-17 | $284.31K derived: sum of 2 quarters · filed 2021-05-17 | $523.71K derived: sum of 3 quarters · filed 2021-05-17 | $814.09K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $167.94K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $407.34K derived: sum of 2 quarters · filed 2021-03-11 | $697.72K derived: sum of 3 quarters · filed 2021-03-11 | $1.03M 10-K · filed 2021-03-11 |
| 2019-09-30 | $239.41K 10-Q · filed 2020-11-10 | $529.78K derived: sum of 2 quarters · filed 2020-11-10 | $862.90K 10-Q · filed 2020-11-10 | $1.21M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $290.38K 10-Q · filed 2020-08-12 | $623.50K 10-Q · filed 2020-08-12 | $971.09K derived: sum of 3 quarters · filed 2020-08-12 | $1.30M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $333.12K 10-Q · filed 2020-05-07 | $680.71K derived: sum of 2 quarters · filed 2020-05-07 | $1.01M derived: sum of 3 quarters · filed 2020-05-07 | $1.06M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $347.59K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $680.64K derived: sum of 2 quarters · filed 2020-03-16 | $727.10K derived: sum of 3 quarters · filed 2020-03-16 | $778.22K 10-K · filed 2020-03-16 |
| 2018-09-30 | $333.05K 10-Q · filed 2019-11-07 | $379.51K derived: sum of 2 quarters · filed 2019-11-07 | $430.63K 10-Q · filed 2019-11-07 | $484.46K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $46.46K 10-Q · filed 2019-08-08 | $97.58K 10-Q · filed 2019-08-08 | $151.41K derived: sum of 3 quarters · filed 2019-08-08 | $211.26K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $51.12K 10-Q · filed 2019-05-09 | $104.95K derived: sum of 2 quarters · filed 2019-05-09 | $164.79K derived: sum of 3 quarters · filed 2019-05-09 | $217.11K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $53.83K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $113.68K derived: sum of 2 quarters · filed 2019-03-07 | $165.99K derived: sum of 3 quarters · filed 2019-03-07 | -$105.78K 10-K · filed 2019-03-07 |
| 2017-09-30 | $59.85K 10-Q · filed 2018-11-07 | $112.16K derived: sum of 2 quarters · filed 2018-11-07 | -$159.61K 10-Q · filed 2018-11-07 | -$387.26K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $52.32K 10-Q · filed 2018-08-14 | -$219.46K 10-Q · filed 2018-08-14 | -$447.11K derived: sum of 3 quarters · filed 2018-08-14 | -$613.96K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$271.77K 10-Q · filed 2018-05-15 | -$499.43K derived: sum of 2 quarters · filed 2018-05-15 | -$666.27K derived: sum of 3 quarters · filed 2018-05-15 | -$755.06K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$227.65K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$394.50K derived: sum of 2 quarters · filed 2018-03-15 | -$483.28K derived: sum of 3 quarters · filed 2018-03-15 | -$482.20K 10-K · filed 2018-03-15 |
| 2016-09-30 | -$166.85K 10-Q · filed 2017-11-13 | -$255.63K derived: sum of 2 quarters · filed 2017-11-13 | -$254.55K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$88.78K 10-Q · filed 2017-08-10 | -$87.71K 10-Q · filed 2017-08-10 | ||
| 2016-03-31 | $1.08K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |